1)Doi M, Usui N, Shimada S:Prenatal environment and neurodevelopmental disorders. Front Endocrinol (Lausanne)13:860110, 2022
2)Coles CD, Kalberg W, Kable JA, et al:Characterizing alcohol-related neurodevelopmental disorder:prenatal alcohol exposure and the spectrum of outcomes. Alcohol Clin Exp Res 44:1245-1260, 2020
3)Nakamura A, Francois O, Lepeule J:Epigenetic alterations of maternal tobacco smoking during pregnancy:a narrative review. Int J Environ Res Public Health 18:5083, 2021
4)Creeley CE, Denton LK:Use of prescribed psychotropics during pregnancy:a systematic review of pregnancy, neonatal, and childhood outcomes. Brain Sci 14:235, 2019
5)El Marroun H, White T, Verhulst FC, et al:Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes:a systematic review. Eur Child Adolesc Psychiatry 23:973-992, 2014
6)Halfdanarson O, Cohen JM, Karlstad O, et al:Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder:a Nordic cohort study. Evid Based Ment Health 25:54-62, 2022